125
Participants
Start Date
February 28, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
AIN457
AIN457 300mg s.c weekly for 3 weeks then every 2 weeks
AIN457
AIN457 300mg s.c at baseline and Week 2 then every 4 weeks
AIN457
AIN457 150mg s.c at baseline and Week 2 then every 4 weeks
Placebo
Placebo s.c weekly for 3 weeks then every 2 weeks
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Bern
Novartis Investigative Site, Bern
Novartis Investigative Site, Lucerne
Novartis Investigative Site, Zurich
Novartis Investigative Site, Zurich
Novartis Investigative Site, Sankt Gallen
Novartis Investigative Site, Berlin
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
The Wilmer Eye Institute, Baltimore
Novartis Investigative Site, Kiel
Charlotte Eye, Ear, Nose, and Throat Associates, Belmont
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Charlotte
Emory University, Atlanta
Novartis Investigative Site, Atlanta
Novartis Investigative Site, Fatih / Istanbul
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Louisville
University of Louisville Opthamology, Louisville
Novartis Investigative Site, Parma
Novartis Investigative Site, Parma
Novartis Investigative Site, Essen
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Münster
Novartis Investigative Site, Barakaldo
Novartis Investigative Site, Barakaldo
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Ancona
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Arlington
Texas Retina Associates, Arlington
Houston Eye Associates, Houston
Novartis Investigative Site, Houston
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Beverly Hills
Retina-Vitreous Assoc. Medical Group, Beverly Hills
Sall Research Medical Center, Artesia
Novartis Investigative Site, Artesia
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Portland
OHSU, Casey Eye Institute, Portland
University of Washington, Seattle
Novartis Investigative Site, Seattle
Novartis Investigative Site, Chennai
Novartis Investigative Site, Chennai
Novartis Investigative Site, Madurai
Novartis Investigative Site, Madurai
Novartis Investigative SIte, Coimbatore
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Baltimore
Massachusets Eye Research and Surgery Institution (MERSI), Cambridge
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Teaneck
The Cornea and Laser Institute and UMDNJ, Teaneck
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Dessau
Novartis Investigative Site, Dessau
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Chandigarh
Novartis Investigative Site, Kolkata
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Bristol
Novartis Investigative Site, Bristol
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, York
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY